Abstract
Bovine serum albumin-loaded beads were prepared by ionotropic gelation of alginate with calcium chloride and chitosan. The effect of sodium alginate concentration and chitosan concentration on the particle size and loading efficacy was studied. The diameter of the beads formed is dependent on the size of the needle used. The optimum condition for preparation alginate–chitosan beads was alginate concentration of 3% and chitosan concentration of 0.25% at pH 5. The resulting bead formulation had a loading efficacy of 98.5% and average size of 1,501 μm, and scanning electron microscopy images showed spherical and smooth particles. Chitosan concentration significantly influenced particle size and encapsulation efficiency of chitosan–alginate beads (p < 0.05). Decreasing the alginate concentration resulted in an increased release of albumin in acidic media. The rapid dissolution of chitosan–alginate matrices in the higher pH resulted in burst release of protein drug.
Similar content being viewed by others
References
Hwang S, Park H, Park K. Gastric retentive drug delivery systems. Crit Rev Ther Drug Carr Syst. 1998;15:243–84.
Lee VH, Grass GM, Dodda-Kashi S, Rubas W. Oral route of peptide and protein drug delivery. In: Lee VH, editor. peptide and protein drug delivery. New York: Marcel & Dekker; 1991. p. 691–741.
Ingemann M, Frokjaer S, Hovgaard L. Peptide and protein drug delivery systems for non-parenteral routes of administration. In: Frokjaer S, Hovgaard L, editors. Pharmaceutical formulation development of peptides and proteins. Philadelphia: Taylor & Francis; 2000. p. 189–203.
George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review. J Cont Rel. 2006;114:1–14.
Gombotz WR, Wee SF. Protein release from alginate matrices. Adv Drug Deliv Rev. 1998;31:267–85.
Tonnesen HH, Karlsen J. Alginate in drug delivery. Drug Dev Ind Pharm. 2002;28:621–30.
Takka S, Acartürk F. Calcium alginate microparticles for oral administration: I. Effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul. 1999;16:275–90.
Aral C, Akbuğa J. Alternative approach to the preparation of chitosan beads. Int J Pharm Sci. 1998;168:9–15.
Şenel S, Hıncal AA. Drug permeation enhencement via buccal route: possibilities and limitations. J Contr Rel. 2001;72:133–44.
Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. Chitosan–alginate microparticles as a protein carrier. Drug Dev Ind Pharm. 2001;27:393–400.
Douglas KL, Tabriziani M. Effect of experimental parameters on the formation of alginate–chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polym ed. 2005;16:43–56.
Polk A, Amsden B, De Yao K, Peng T, Goosen MFA. Controlled release of albumin from chitosan alginate microcapsules. J Pharm Sci. 1994;83:178–85.
Zhang L, Guo J, Peng X, Jin Y. Preparation and release behavior of carboxymethylated chitosan/alginate microspheres encapsulating bovine serum albumin. J Appl Polym Sci. 2004;92:878–82.
Hari PR, Chandy T, Sharma CP. Chitosan/calcium alginate beads for oral delivery of insulin. J Appl Polym Sci. 1996;59:1795–801.
Vandenberg GW, De La Noüe L. Evaluation of protein release from chitosan–alginate microcapsules produced using external or internal gelation. J Microencapsul. 2001;18:433–41.
Narendera C, Srinath MS, Prakash Rao B. Development of three layered buccal compact containing metoprolol tartrate by statistical optimization technique. Int J Pharm. 2005;304:102–14.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–75.
Takka S, Ocak Ö, Acartürk F. Calcium alginate microparticles for oral administration: II. Effect of formulation factors on drug release and drug entrapment efficieny. Eur J Pharm Sci. 1998;6:241–6.
Mi FL, Sung HW, Shyu SS. Drug release from chitosan–alginate complex beads reinforced by a naturally occurring cross-linking agent. Carbohyd Polym. 2002;48:61–72.
Gåserød O, Sannes A, Skjak-Braek G. Microcapsules of alginate–chitosan. II. A study of capsule stability and permeability. Biomaterials. 1999;20:773–83.
Takahashi T, Takayama K, Machida Y, Nagai T. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int J Pharm. 1990;61:35–41.
Gazori T, Khoshayand MR, Azizi E, Yazdizade P. Evaluation of alginate/chitosan nanoparticles as antisense delivery vector: formulation, optimaztion and in vitro characterization. Carbohydr Polym. 2009;77:599–606.
Motwari SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK. Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm. 2008;68:513–25.
Lewis GA, Luu RP, Mathiey D. Pharmaceutical experimental design. New York: Marcel Dekker; 1999.
Acknowledgments
This study was supported by a grant from Gazi University (02/2002-03).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takka, S., Gürel, A. Evaluation of Chitosan/Alginate Beads Using Experimental Design: Formulation and In Vitro Characterization. AAPS PharmSciTech 11, 460–466 (2010). https://doi.org/10.1208/s12249-010-9406-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-010-9406-z